SCHEMBL9627657

SCHEMBL9627657

CCCCOC1=C(CC)C(=O)c2ccccc2C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.53
MAPT P10636 5/20 0.44
TDP1 Q9NUW8 4/20 0.44
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
CYP1A2 P05177 3/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 3/20 0.44
KDM4E B2RXH2 3/20 0.44
CDC25B P30305 3/20 0.44
LMNA P02545 3/20 0.44
POLB P06746 2/20 0.44
CYP2D6 P10635 2/20 0.44
BLM P54132 2/20 0.44
HIF1A Q16665 2/20 0.44
RAB9A P51151 2/20 0.44
HPGD P15428 2/20 0.44
CDC25A P30304 2/20 0.44
MAP2K7 O14733 1/20 0.44
GMNN O75496 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9627133 0.91 PTPN1 (0.46) PTPN1MAPTTDP1ALDH1A1SMN1; SMN2
SCHEMBL9643214 0.89 PTPN1 (0.58) PTPN1MAPTTDP1ALDH1A1SMN1; SMN2
SCHEMBL9627536 0.87 CDC25B (0.53) PTPN1MAPTTDP1ALDH1A1SMN1; SMN2
SCHEMBL9627500 0.84 CDC25B (0.55) PTPN1MAPTTDP1ALDH1A1SMN1; SMN2
SCHEMBL9629370 0.82 PTPN1 (0.50) PTPN1MAPTTDP1ALDH1A1THRB
SCHEMBL9642876 0.81 PTPN1 (0.64) PTPN1MAPTTDP1ALDH1A1SMN1; SMN2
SCHEMBL9627480 0.81 PTPN1 (0.44) PTPN1MAPTTDP1ALDH1A1SMN1; SMN2
SCHEMBL10705446 0.81 PTPN1 (0.55) PTPN1MAPTTDP1ALDH1A1SMN1; SMN2
SCHEMBL11658545 0.80 PTPN1 (0.51) PTPN1CDC25BPTPRC
SCHEMBL9444224 0.80 PTPN1 (0.51) PTPN1MAPTALDH1A1SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155132-A Nonsteroidal antiinflammatory agents; treating psoriasis SYNTEX (U.S.A.) INC. (US) 1992-10-13 US disclosed
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-5089657-A Topical antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-02-18 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0282056-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
US-4758587-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-07-19 US disclosed